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Background
Reports indicate that cannabinergic agents can change
anxiety-related behaviours in both animals and humans.
The amygdala is an important brain site in the modula-
tion of fear or anxiety.
Materials and methods
In the present study, we investigated the effects of intrac-
entral amygdala microinjection of cannabinergic agents
on anxiety-related behaviours in rats, using the elevated
plus-maze test of anxiety. Intracentral amygdala adminis-
tration of ACPA a cannabinergic potent agonist (0.125,
1.25,5 ng/0.5 μl bilateral) increased %open arm time and
% open arm entries, but not locomotor activity, showing
an anxilytic response. Intracentral amygdala microinjec-
tion of AM251 a potent CB1 antagonist (2.5, 25, 100 ng/
0.5 μl bilateral) did not change anxiety-related parameters
in our experiments.
Results
The results suggest that cannabinergic agonists may
reduce anxiety via CB1 receptors in the rat central amy-
gdala.
Conclusions
Couse that CB1 antagonist didn't show any effect on anx-
iety we think that CB1 isn't the main receptor in central
amygdala.
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